Tania Incitti
AstraZeneca (Brazil)(BR)AstraZeneca (Sweden)(SE)
Publications by Year
Research Areas
Pluripotent Stem Cells Research, Muscle Physiology and Disorders, Tissue Engineering and Regenerative Medicine, 3D Printing in Biomedical Research, MicroRNA in disease regulation
Most-Cited Works
- → MicroRNAs Involved in Molecular Circuitries Relevant for the Duchenne Muscular Dystrophy Pathogenesis Are Controlled by the Dystrophin/nNOS Pathway(2010)248 cited
- → miR‐31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy(2011)153 cited
- → Viability and neuronal differentiation of neural stem cells encapsulated in silk fibroin hydrogel functionalized with an IKVAV peptide(2015)131 cited
- → Neural differentiation of pluripotent cells in 3D alginate-based cultures(2014)112 cited
- → PAX7 Targets, CD54, Integrin α9β1, and SDC2, Allow Isolation of Human ESC/iPSC-Derived Myogenic Progenitors(2017)85 cited
- → Genipin-crosslinked gelatin-silk fibroin hydrogels for modulating the behaviour of pluripotent cells(2014)70 cited
- → Long-Term Benefit of Adeno-Associated Virus/Antisense-Mediated Exon Skipping in Dystrophic Mice(2008)65 cited
- → Gene-mediated Restoration of Normal Myofiber Elasticity in Dystrophic Muscles(2008)54 cited
- → Pluripotent stem cell-derived myogenic progenitors remodel their molecular signature upon in vivo engraftment(2019)51 cited
- → Exon Skipping and Duchenne Muscular Dystrophy Therapy: Selection of the Most Active U1 snRNA Antisense Able to Induce Dystrophin Exon 51 Skipping(2010)39 cited